BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16562858)

  • 21. Induction of glutathione transferases and NAD(P)H:quinone reductase by fumaric acid derivatives in rodent cells and tissues.
    Spencer SR; Wilczak CA; Talalay P
    Cancer Res; 1990 Dec; 50(24):7871-5. PubMed ID: 2123743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of quinone oxidoreductase 1 enzyme by Rhazya stricta through Nrf2-dependent mechanism.
    El Gendy MA; Ali BH; Michail K; Siraki AG; El-Kadi AO
    J Ethnopharmacol; 2012 Nov; 144(2):416-24. PubMed ID: 23026305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes.
    Zhang Y; Talalay P
    Cancer Res; 1998 Oct; 58(20):4632-9. PubMed ID: 9788615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of flavonoids as monofunctional or bifunctional inducers of quinone reductase in murine hepatoma cell lines.
    Yannai S; Day AJ; Williamson G; Rhodes MJ
    Food Chem Toxicol; 1998 Aug; 36(8):623-30. PubMed ID: 9734712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baicalin induces NAD(P)H:quinone reductase through the transactivation of AP-1 and NF-kappaB in Hepa 1c1c7 cells.
    Park HJ; Lee YW; Lee SK
    Eur J Cancer Prev; 2004 Dec; 13(6):521-8. PubMed ID: 15548947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenolics from Barleria cristata var. Alba as carcinogenesis blockers against menadione cytotoxicity through induction and protection of quinone reductase.
    El-Halawany AM; Abdallah HM; Hamed AR; Khalil HE; Almohammadi AM
    BMC Complement Altern Med; 2018 May; 18(1):163. PubMed ID: 29788962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of NAD(P)H quinone: oxidoreductase1 inhibits carcinogen-induced aberrant crypt foci in colons of Sprague-Dawley rats.
    Begleiter A; Sivananthan K; Curphey TJ; Bird RP
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):566-72. PubMed ID: 12815004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprotection against cancer by phase 2 enzyme induction.
    Talalay P; Fahey JW; Holtzclaw WD; Prestera T; Zhang Y
    Toxicol Lett; 1995 Dec; 82-83():173-9. PubMed ID: 8597048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents.
    Izzotti A; Camoirano A; Cartiglia C; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S
    Cancer Res; 1999 Sep; 59(17):4285-90. PubMed ID: 10485473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of quinone reductase (QR) by withanolides isolated from Physalis pubescens L. (Solanaceae).
    Ji L; Yuan Y; Ma Z; Chen Z; Gan L; Ma X; Huang D
    Steroids; 2013 Sep; 78(9):860-5. PubMed ID: 23685089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver.
    Prochaska HJ; Talalay P
    Cancer Res; 1988 Sep; 48(17):4776-82. PubMed ID: 3409219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro.
    Brooks JD; Goldberg MF; Nelson LA; Wu D; Nelson WG
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):868-75. PubMed ID: 12223431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention of colon carcinogenesis by organosulfur compounds.
    Reddy BS; Rao CV; Rivenson A; Kelloff G
    Cancer Res; 1993 Aug; 53(15):3493-8. PubMed ID: 8339252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer chemopreventive activity of sulforamate derivatives.
    Moriarty RM; Naithani R; Kosmeder J; Prakash O
    Eur J Med Chem; 2006 Jan; 41(1):121-4. PubMed ID: 16300858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro induction of the anticarcinogenic marker enzyme, quinone reductase, in human hepatoma cells by food extracts.
    Hashimoto K; Kawamata S; Usui N; Tanaka A; Uda Y
    Cancer Lett; 2002 Jun; 180(1):1-5. PubMed ID: 11911963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of quinone reductase activity by stilbene analogs in mouse Hepa 1c1c7 cells.
    Heo YH; Kim S; Park JE; Jeong LS; Lee SK
    Arch Pharm Res; 2001 Dec; 24(6):597-600. PubMed ID: 11794542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of induction of enzymes that protect against chemical carcinogenesis.
    Talalay P
    Adv Enzyme Regul; 1989; 28():237-50. PubMed ID: 2696344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid detection of inducers of enzymes that protect against carcinogens.
    Prochaska HJ; Santamaria AB; Talalay P
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2394-8. PubMed ID: 1549602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoprevention by 1,2-dithiole-3-thiones through induction of NQO1 and other phase 2 enzymes.
    Kwak MK; Ramos-Gomez M; Wakabayashi N; Kensler TW
    Methods Enzymol; 2004; 382():414-23. PubMed ID: 15047114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.